ストックスクリーナーアプリを入手
3.49
4.64%
-0.17
アフターアワーズ：
3.51
0.02
+0.57%
前日終値:
$3.66
開ける：
$3.61
24時間の取引高:
24.93M
Relative Volume:
2.98
時価総額：
$2.11B
収益：
$29.48M
当期純損益:
$-201.19M
株価収益率:
-10.26
EPS:
-0.34
ネットキャッシュフロー:
$-216.50M
1週間 パフォーマンス:
-9.59%
1か月 パフォーマンス:
-12.53%
6か月 パフォーマンス:
-21.75%
1年 パフォーマンス:
+61.57%
1日の値動き範囲:
$3.455
$3.685
1週間の範囲:
$3.455
$4.00
52週間の値動き範囲:
$1.64
$5.34
Geron Corp Stock (GERN) Company Profile
名前
Geron Corp
セクター
電話
(650) 473-7700
住所
919 EAST HILLSDALE BOULEVARD, FOSTER CITY, CA
GERN を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
GERN
Geron Corp
|
3.49 | 2.11B | 29.48M | -201.19M | -216.50M | -0.32 |
|
VRTX
Vertex Pharmaceuticals Inc
|
397.27 | 102.31B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
701.85 | 77.13B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
623.82 | 37.30B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
245.44 | 31.66B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
113.08 | 27.11B | 3.30B | -501.07M | 1.03B | -2.1146 |
Geron Corp Stock (GERN) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-11-05 | 開始されました | H.C. Wainwright | Buy |
| 2024-10-16 | 開始されました | Scotiabank | Sector Outperform |
| 2024-09-09 | 開始されました | Leerink Partners | Outperform |
| 2024-04-30 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2024-04-29 | 開始されました | TD Cowen | Buy |
| 2024-03-15 | 繰り返されました | Needham | Buy |
| 2023-09-12 | アップグレード | Goldman | Neutral → Buy |
| 2023-03-28 | 開始されました | Goldman | Neutral |
| 2022-10-28 | 開始されました | Wedbush | Outperform |
| 2022-07-28 | 再開されました | B. Riley Securities | Buy |
| 2021-11-02 | 開始されました | Robert W. Baird | Outperform |
| 2021-02-18 | 再開されました | B. Riley Securities | Buy |
| 2020-08-03 | 開始されました | Stifel | Buy |
| 2019-11-19 | 再開されました | B. Riley FBR | Buy |
| 2019-09-03 | 開始されました | H.C. Wainwright | Buy |
| 2019-08-15 | 開始されました | Cantor Fitzgerald | Overweight |
| 2019-04-09 | アップグレード | Needham | Hold → Buy |
| 2019-01-31 | アップグレード | B. Riley FBR | Neutral → Buy |
| 2018-10-02 | ダウングレード | B. Riley FBR | Buy → Neutral |
| 2018-07-05 | 開始されました | B. Riley FBR, Inc. | Buy |
| 2016-09-13 | 繰り返されました | FBR & Co. | Outperform |
| 2016-09-13 | 繰り返されました | FBR Capital | Outperform |
| 2015-12-07 | 繰り返されました | Piper Jaffray | Overweight |
| 2015-04-21 | 開始されました | Oppenheimer | Outperform |
| 2014-06-12 | アップグレード | MLV & Co | Hold → Buy |
| 2014-03-12 | ダウングレード | MLV & Co | Buy → Hold |
| 2013-12-10 | 繰り返されました | MLV & Co | Buy |
| 2013-12-10 | アップグレード | Needham | Hold → Buy |
| 2013-11-08 | 繰り返されました | MLV & Co | Buy |
| 2013-10-16 | 開始されました | MLV & Co | Buy |
| 2012-08-30 | 開始されました | Stifel Nicolaus | Buy |
| 2012-06-28 | 開始されました | Needham | Hold |
すべてを表示
Geron Corp (GERN) 最新ニュース
Geron (NASDAQ:GERN) Stock Price Down 2.5%Here's Why - MarketBeat
Barclays PLC Has $5.90 Million Stock Holdings in Geron Co. (NASDAQ:GERN) - MarketBeat
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Yahoo Finance
Geron Corporation (NASDAQ:GERN) is a favorite amongst institutional investors who own 72% - Yahoo Finance
Geron (NASDAQ:GERN) Shares Up 3.7%Here's Why - MarketBeat
Geron Co. (NASDAQ:GERN) Short Interest Down 5.4% in November - MarketBeat
Geron's SWOT analysis: biotech stock shows promise amid challenges - Investing.com
Geron Co. (NASDAQ:GERN) Shares Sold by MML Investors Services LLC - MarketBeat
State Street Corp Grows Stock Position in Geron Co. (NASDAQ:GERN) - MarketBeat
Exome Asset Management LLC Invests $4.11 Million in Geron Co. (NASDAQ:GERN) - MarketBeat
Geron announces positive CHMP opinion for Rytelo - Yahoo Finance
Geron's (GERN) Buy Rating Reaffirmed at Needham & Company LLC - MarketBeat
World Investment Advisors LLC Increases Stake in Geron Co. (NASDAQ:GERN) - MarketBeat
Geron's RYTELO nears EU approval for certain blood cancers - Investing.com
Geron Announces Positive CHMP Opinion for RYTELO™ (imetelstat) for the Treatment of Adults with Transfusion-Dependent Anemia due to Lower-Risk MDS - Yahoo Finance
Geron Co. (NASDAQ:GERN) Shares Bought by Wellington Management Group LLP - MarketBeat
Stifel sustains Buy on Geron, steady stock target amid ASH updates - Investing.com Canada
What is Leerink Partnrs' Forecast for Geron FY2026 Earnings? - MarketBeat
Geron Co. (NASDAQ:GERN) Shares Bought by BNP Paribas Financial Markets - MarketBeat
Is Geron Corporation (GERN) the Best NASDAQ Penny Stock to Buy Right Now? - Insider Monkey
Imetelstat shows promise for LR-MDS patients post other therapies - Investing.com
Geron's RYTELO Shows Strong Safety Profile in Phase 1 Myelofibrosis Trial at ASH Meeting - StockTitan
HC Wainwright Reaffirms "Buy" Rating for Geron (NASDAQ:GERN) - MarketBeat
Analyst Scoreboard: 4 Ratings For Geron - Benzinga
The Manufacturers Life Insurance Company Sells 220,414 Shares of Geron Co. (NASDAQ:GERN) - MarketBeat
Geron Co. (NASDAQ:GERN) Stock Position Lessened by Fmr LLC - MarketBeat
Geron Co. (NASDAQ:GERN) Shares Sold by RA Capital Management L.P. - MarketBeat
RTW Investments LP Makes New $200.27 Million Investment in Geron Co. (NASDAQ:GERN) - MarketBeat
Janus Henderson Group PLC Acquires 13,163,889 Shares of Geron Co. (NASDAQ:GERN) - MarketBeat
Geron's SWOT analysis: biopharmaceutical stock poised for growth amid challenges - Investing.com
Geron Co. (NASDAQ:GERN) Given Average Recommendation of "Buy" by Brokerages - MarketBeat
Walleye Capital LLC Purchases New Shares in Geron Co. (NASDAQ:GERN) - MarketBeat
Geron (NASDAQ:GERN) Trading Down 3.1%Here's What Happened - MarketBeat
Vestal Point Capital LP Purchases New Stake in Geron Co. (NASDAQ:GERN) - MarketBeat
Geron Co. (NASDAQ:GERN) Shares Sold by Ally Bridge Group NY LLC - MarketBeat
Acuta Capital Partners LLC Acquires New Shares in Geron Co. (NASDAQ:GERN) - MarketBeat
Intech Investment Management LLC Invests $1.10 Million in Geron Co. (NASDAQ:GERN) - MarketBeat
Geron Co. (NASDAQ:GERN) Shares Purchased by Algert Global LLC - MarketBeat
Geron to Present at Evercore ISI HealthCONx Conference This December - StockTitan
Geron Corp. (GERN): Among the NASDAQ Stocks with Biggest Upside Potential According to Analysts - Insider Monkey
12 NASDAQ Stocks with Biggest Upside Potential According to Analysts - Insider Monkey
Geron Grants 1M Stock Options to New Hires at $3.99 Exercise Price | GERN Stock News - StockTitan
Geron: A Strong Launch And Financial Deals Make It Attractive (NASDAQ:GERN) - Seeking Alpha
Akin Advises Pharmakon Advisors in its $250 Million Debt Financing for Geron Corporation - Akin Gump Strauss Hauer & Feld LLP
First Turn Management LLC Takes $14.19 Million Position in Geron Co. (NASDAQ:GERN) - MarketBeat
RA Capital Management's Strategic Acquisition of Geron Corp Shar - GuruFocus.com
Deep Track Capital's Strategic Reduction in Geron Corp Holdings - GuruFocus.com
RTW INVESTMENTS, LP Acquires New Stake in Geron Corp - GuruFocus.com
GERNGeron Corp Latest Stock News & Market Updates - StockTitan
Geron's SWOT analysis: oncology biotech stock poised for growth - Investing.com
Geron Strengthens Leadership: Top Oncology Expert Dr. Eid Joins as EVP of R&D | GERN Stock News - StockTitan
Geron Corp (GERN) 財務データ
収益
当期純利益
現金流量
EPS
Geron Corp (GERN) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| GRETHLEIN ANDREW J | EVP, Chief Operating Officer |
Jul 08 '24 |
Sale |
4.56 |
674,348 |
3,073,004 |
0 |
| Feller Faye | EVP, Chief Medical Officer |
Jun 10 '24 |
Option Exercise |
1.19 |
287,900 |
341,693 |
155,400 |
| Feller Faye | EVP, Chief Medical Officer |
Jun 10 '24 |
Sale |
4.63 |
287,900 |
1,334,129 |
0 |
| Kapur Anil | EVP, Corp Strategy & CCO |
Jun 10 '24 |
Option Exercise |
1.06 |
421,875 |
447,188 |
421,875 |
| Kapur Anil | EVP, Corp Strategy & CCO |
Jun 10 '24 |
Sale |
4.64 |
421,875 |
1,959,609 |
0 |
| SCARLETT JOHN A | Chairman, President and CEO |
Jun 04 '24 |
Option Exercise |
2.54 |
600,000 |
1,524,000 |
600,000 |
| SCARLETT JOHN A | Chairman, President and CEO |
Jun 04 '24 |
Sale |
4.00 |
600,000 |
2,400,000 |
600,000 |
| LAWLIS V BRYAN | Director |
May 15 '24 |
Option Exercise |
1.94 |
35,000 |
67,900 |
35,000 |
| LAWLIS V BRYAN | Director |
May 15 '24 |
Sale |
3.75 |
35,000 |
131,250 |
0 |
2.88%
2.65%
大文字化:
|
ボリューム (24 時間):